Karyopharm Therapeutics Inc. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Karyopharm Therapeutics Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2016-12-31 was $105.00K, a 53.74% decline year-over-year.
- Karyopharm Therapeutics Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2016-09-30 was $0.00.
- Karyopharm Therapeutics Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2015-12-31 was $227.00K, a 60.99% increase year-over-year.
- Karyopharm Therapeutics Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2015-09-30 was $0.00.
- Karyopharm Therapeutics Inc. stock issued during period, value, employee stock purchase plan for fiscal 2016 was $340.00K, a 3.41% decline from fiscal 2015.
- Karyopharm Therapeutics Inc. stock issued during period, value, employee stock purchase plan for fiscal 2015 was $352.00K, a 149.65% increase from fiscal 2014.
- Karyopharm Therapeutics Inc. stock issued during period, value, employee stock purchase plan for fiscal 2014 was $141.00K.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2016-12-31 | $105.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $340.00K 10-K · filed 2017-03-16 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | |
| 2015-12-31 | $227.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $352.00K 10-K · filed 2017-03-16 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | |
| 2014-12-31 | $141.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $141.00K 10-K · filed 2017-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |